Insomnia recovery rates of 56% and cost savings of £1.8m in primary care

Big Health and the Oxford AHSN have embedded Sleepio's digital CBT in the NHS safely and at scale.

In over 7,000 Sleepio patients, usage resulted in insomnia recovery rates of 56% and reductions in anxiety and depression symptoms of over 70%. Moreover, an independent health economics study has found Sleepio delivers significant cost savings in primary care and reduces prescription medications usage - representing a saving of £1.8m across BOB ICS in three years.

These outcomes are matched by positive patient and clinician feedback, adding to the growing body of real-world evidence supporting the use of digital therapeutics in the NHS.